

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.23984401 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.85786907 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.84272671 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.84272671 |
| 5 | response to peptidoglycan (GO:0032494) | 5.54023107 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.39289869 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.39289869 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.39289869 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.39289869 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.39289869 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 5.39289869 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 5.07347864 |
| 13 | cellular extravasation (GO:0045123) | 4.80743393 |
| 14 | regulation of interferon-alpha production (GO:0032647) | 4.79503155 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.76119983 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.71327226 |
| 17 | detection of bacterium (GO:0016045) | 4.65319365 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.54534205 |
| 19 | respiratory burst (GO:0045730) | 4.44059445 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.43843764 |
| 21 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.43177532 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.42095753 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30047376 |
| 24 | granulocyte activation (GO:0036230) | 4.25831613 |
| 25 | superoxide anion generation (GO:0042554) | 4.20961039 |
| 26 | neutrophil activation (GO:0042119) | 4.20243314 |
| 27 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.12981402 |
| 28 | microglial cell activation (GO:0001774) | 4.07465474 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.03993042 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 4.01476711 |
| 31 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.97247048 |
| 32 | detection of biotic stimulus (GO:0009595) | 3.95731461 |
| 33 | reactive oxygen species biosynthetic process (GO:1903409) | 3.95058755 |
| 34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.85515191 |
| 35 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.84280273 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.82477667 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.81150289 |
| 38 | response to host immune response (GO:0052572) | 3.79707123 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.79707123 |
| 40 | response to muramyl dipeptide (GO:0032495) | 3.79430510 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.77525523 |
| 42 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.72357272 |
| 43 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.71910003 |
| 44 | regulation of mononuclear cell migration (GO:0071675) | 3.71632865 |
| 45 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.70854044 |
| 46 | positive regulation of interferon-beta production (GO:0032728) | 3.70035166 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.69969492 |
| 48 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.69969492 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.68465473 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.68465473 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 3.66037502 |
| 52 | response to type I interferon (GO:0034340) | 3.63280859 |
| 53 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.59983234 |
| 54 | cellular response to interferon-beta (GO:0035458) | 3.58905258 |
| 55 | positive regulation of mast cell activation (GO:0033005) | 3.56463732 |
| 56 | macrophage activation (GO:0042116) | 3.53268774 |
| 57 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.50779599 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 3.48749194 |
| 59 | regulation of tolerance induction (GO:0002643) | 3.48452802 |
| 60 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.47201231 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.46547577 |
| 62 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.46111150 |
| 63 | B cell mediated immunity (GO:0019724) | 3.45035728 |
| 64 | regulation of antigen processing and presentation (GO:0002577) | 3.44012179 |
| 65 | negative regulation of interleukin-17 production (GO:0032700) | 3.43826532 |
| 66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41519138 |
| 67 | natural killer cell mediated immunity (GO:0002228) | 3.40867856 |
| 68 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.40867856 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.40405208 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 3.39536240 |
| 71 | response to host (GO:0075136) | 3.39050348 |
| 72 | response to host defenses (GO:0052200) | 3.39050348 |
| 73 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.39050348 |
| 74 | regulation of leukocyte degranulation (GO:0043300) | 3.37838783 |
| 75 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.37162019 |
| 76 | cellular response to exogenous dsRNA (GO:0071360) | 3.36074413 |
| 77 | positive regulation of interleukin-12 production (GO:0032735) | 3.36029999 |
| 78 | response to interleukin-15 (GO:0070672) | 3.35002506 |
| 79 | response to interferon-beta (GO:0035456) | 3.34755760 |
| 80 | T-helper 1 type immune response (GO:0042088) | 3.34238261 |
| 81 | defense response to protozoan (GO:0042832) | 3.34101356 |
| 82 | regulation of chemokine biosynthetic process (GO:0045073) | 3.34078123 |
| 83 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.32690779 |
| 84 | myeloid dendritic cell differentiation (GO:0043011) | 3.32284890 |
| 85 | germinal center formation (GO:0002467) | 3.30167851 |
| 86 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29733489 |
| 87 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.28596438 |
| 88 | response to interferon-alpha (GO:0035455) | 3.27690733 |
| 89 | negative regulation of viral genome replication (GO:0045071) | 3.24436516 |
| 90 | regulation of mast cell activation (GO:0033003) | 3.22671715 |
| 91 | leukocyte mediated cytotoxicity (GO:0001909) | 3.21537026 |
| 92 | lymphocyte chemotaxis (GO:0048247) | 3.20990751 |
| 93 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.20809506 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 3.20652982 |
| 95 | detection of other organism (GO:0098543) | 3.20350961 |
| 96 | myeloid leukocyte mediated immunity (GO:0002444) | 3.19892376 |
| 97 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19607825 |
| 98 | myeloid dendritic cell activation (GO:0001773) | 3.19379678 |
| 99 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19264027 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.17819939 |
| 101 | detection of molecule of bacterial origin (GO:0032490) | 3.17532751 |
| 102 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.16668668 |
| 103 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.16326775 |
| 104 | eosinophil chemotaxis (GO:0048245) | 3.14820588 |
| 105 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.14589441 |
| 106 | leukocyte degranulation (GO:0043299) | 3.12630462 |
| 107 | B cell receptor signaling pathway (GO:0050853) | 3.12391386 |
| 108 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10612087 |
| 109 | positive regulation of lymphocyte migration (GO:2000403) | 3.10464438 |
| 110 | cellular response to interleukin-15 (GO:0071350) | 3.09737127 |
| 111 | cellular response to zinc ion (GO:0071294) | 3.09331001 |
| 112 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06575654 |
| 113 | myeloid leukocyte activation (GO:0002274) | 3.05345000 |
| 114 | regulation of activation of Janus kinase activity (GO:0010533) | 3.03946166 |
| 115 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.02959340 |
| 116 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02369960 |
| 117 | positive regulation of heat generation (GO:0031652) | 3.01660837 |
| 118 | dendritic cell chemotaxis (GO:0002407) | 3.01255130 |
| 119 | monocyte chemotaxis (GO:0002548) | 3.01028325 |
| 120 | positive regulation of B cell differentiation (GO:0045579) | 3.00673156 |
| 121 | negative regulation of interleukin-12 production (GO:0032695) | 3.00293608 |
| 122 | leukocyte aggregation (GO:0070486) | 2.98318366 |
| 123 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.97888814 |
| 124 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97849711 |
| 125 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.97815073 |
| 126 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.97483801 |
| 127 | dendritic cell migration (GO:0036336) | 2.97132491 |
| 128 | negative regulation of mast cell activation (GO:0033004) | 2.94783504 |
| 129 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.94562663 |
| 130 | neutrophil chemotaxis (GO:0030593) | 2.94152470 |
| 131 | regulation of B cell differentiation (GO:0045577) | 2.93547657 |
| 132 | negative regulation of interleukin-6 production (GO:0032715) | 2.93271118 |
| 133 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.93063766 |
| 134 | neutrophil mediated immunity (GO:0002446) | 2.92703713 |
| 135 | regulation of interleukin-12 production (GO:0032655) | 2.92187574 |
| 136 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92018825 |
| 137 | positive regulation of chemokine production (GO:0032722) | 2.91918063 |
| 138 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.91834520 |
| 139 | regulation of regulated secretory pathway (GO:1903305) | 2.91339717 |
| 140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90547094 |
| 141 | positive regulation of tolerance induction (GO:0002645) | 2.89653313 |
| 142 | response to protozoan (GO:0001562) | 2.89296878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.87889426 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.81269220 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.45300050 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.77442240 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.48958804 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.41026478 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.28061453 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.70589233 |
| 9 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.69504569 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.48979903 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32105494 |
| 12 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.96852263 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.92400110 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90514327 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.87740112 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74358136 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.52384456 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34608845 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.16727237 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05881934 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03894715 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.03679961 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91887956 |
| 24 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.86975396 |
| 25 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79880651 |
| 26 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78535369 |
| 27 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76197093 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74001943 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73528351 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70379709 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.69435990 |
| 32 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.67584815 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65781969 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63520465 |
| 35 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62098184 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61560247 |
| 37 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.59746094 |
| 38 | * MYB_26560356_Chip-Seq_TH2_Human | 1.55292629 |
| 39 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.54972709 |
| 40 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50630827 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43540263 |
| 42 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40833579 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38573722 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37874428 |
| 45 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36989755 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36506267 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36120109 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34887989 |
| 49 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34544466 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30248058 |
| 51 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25559718 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.25495746 |
| 53 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23317482 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23274843 |
| 55 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23034554 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21832460 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18634125 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17699320 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.16571957 |
| 60 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.16416553 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16021453 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15068841 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11845670 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11033176 |
| 65 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08258243 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08098445 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08053168 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07968551 |
| 69 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07044317 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06797415 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05114059 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03883729 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03037651 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00055749 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98301674 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97236922 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97149846 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96257342 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96118180 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95922896 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93281273 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90203591 |
| 83 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87505539 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86874707 |
| 85 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82442861 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82211169 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82211169 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81679208 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80087496 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76615908 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74898401 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74608908 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74366375 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 0.74280165 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73309268 |
| 96 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.73098960 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73085606 |
| 98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71689303 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71555976 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70354128 |
| 101 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69585960 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.67106475 |
| 103 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63370215 |
| 104 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.62783238 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.61452667 |
| 106 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61419627 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61208903 |
| 108 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.60626071 |
| 109 | MAF_26560356_Chip-Seq_TH2_Human | 0.60253766 |
| 110 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.59748429 |
| 111 | CJUN_26792858_Chip-Seq_BT549_Human | 0.59445064 |
| 112 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.57859202 |
| 113 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57807639 |
| 114 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.57015599 |
| 115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.55407543 |
| 116 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.54652117 |
| 117 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.54187523 |
| 118 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.54065035 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.53568316 |
| 120 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.53187204 |
| 121 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.53187204 |
| 122 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.53153169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.09670331 |
| 2 | MP0009785_altered_susceptibility_to | 4.03454208 |
| 3 | MP0003436_decreased_susceptibility_to | 3.96326669 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 3.93491715 |
| 5 | MP0006082_CNS_inflammation | 3.69098477 |
| 6 | MP0002419_abnormal_innate_immunity | 3.46135941 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.38691508 |
| 8 | MP0003724_increased_susceptibility_to | 3.36779772 |
| 9 | * MP0005025_abnormal_response_to | 3.10817288 |
| 10 | MP0005671_abnormal_response_to | 2.98892292 |
| 11 | MP0003303_peritoneal_inflammation | 2.94757242 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.82853902 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.79206348 |
| 14 | MP0000685_abnormal_immune_system | 2.73529246 |
| 15 | MP0005387_immune_system_phenotype | 2.71661019 |
| 16 | MP0001790_abnormal_immune_system | 2.71661019 |
| 17 | MP0002723_abnormal_immune_serum | 2.59467600 |
| 18 | MP0001800_abnormal_humoral_immune | 2.56526053 |
| 19 | MP0004510_myositis | 2.46377533 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.36706437 |
| 21 | MP0001819_abnormal_immune_cell | 2.33246693 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.28944375 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.22807592 |
| 24 | MP0001853_heart_inflammation | 2.18734632 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.12474227 |
| 26 | MP0009764_decreased_sensitivity_to | 2.03894879 |
| 27 | MP0002405_respiratory_system_inflammati | 1.98482026 |
| 28 | * MP0001845_abnormal_inflammatory_respons | 1.94438813 |
| 29 | MP0003075_altered_response_to | 1.85164307 |
| 30 | MP0003172_abnormal_lysosome_physiology | 1.83604766 |
| 31 | MP0000343_altered_response_to | 1.81946574 |
| 32 | MP0004947_skin_inflammation | 1.77468873 |
| 33 | MP0009278_abnormal_bone_marrow | 1.76165219 |
| 34 | MP0008469_abnormal_protein_level | 1.75505336 |
| 35 | MP0005310_abnormal_salivary_gland | 1.72014472 |
| 36 | MP0003448_altered_tumor_morphology | 1.69918494 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.69612476 |
| 38 | MP0002006_tumorigenesis | 1.66764823 |
| 39 | MP0000716_abnormal_immune_system | 1.59338001 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.58683471 |
| 41 | MP0002998_abnormal_bone_remodeling | 1.51110685 |
| 42 | MP0002398_abnormal_bone_marrow | 1.45885196 |
| 43 | MP0000858_altered_metastatic_potential | 1.44397617 |
| 44 | MP0003690_abnormal_glial_cell | 1.43051956 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.42498311 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.41154331 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.41154331 |
| 48 | MP0009840_abnormal_foam_cell | 1.36075023 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.35307954 |
| 50 | MP0005166_decreased_susceptibility_to | 1.29327850 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.26437881 |
| 52 | MP0002429_abnormal_blood_cell | 1.25719666 |
| 53 | MP0005164_abnormal_response_to | 1.22624294 |
| 54 | MP0003828_pulmonary_edema | 1.21998681 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.20188363 |
| 56 | MP0004381_abnormal_hair_follicle | 1.16991696 |
| 57 | MP0003186_abnormal_redox_activity | 1.12096217 |
| 58 | MP0002722_abnormal_immune_system | 1.10822761 |
| 59 | MP0000604_amyloidosis | 1.10494654 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.07782831 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.05646413 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.04633065 |
| 63 | MP0005390_skeleton_phenotype | 1.01602261 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 0.98062010 |
| 65 | MP0009763_increased_sensitivity_to | 0.97731187 |
| 66 | MP0002396_abnormal_hematopoietic_system | 0.95890519 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 0.93580505 |
| 68 | MP0004883_abnormal_blood_vessel | 0.89861932 |
| 69 | MP0000015_abnormal_ear_pigmentation | 0.89415433 |
| 70 | MP0002933_joint_inflammation | 0.88529024 |
| 71 | MP0002254_reproductive_system_inflammat | 0.87957554 |
| 72 | MP0010307_abnormal_tumor_latency | 0.87067216 |
| 73 | MP0001663_abnormal_digestive_system | 0.86091357 |
| 74 | MP0000371_diluted_coat_color | 0.85480040 |
| 75 | MP0003195_calcinosis | 0.81243992 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.78730917 |
| 77 | MP0001851_eye_inflammation | 0.78397692 |
| 78 | MP0008260_abnormal_autophagy | 0.74339804 |
| 79 | * MP0000249_abnormal_blood_vessel | 0.71107009 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.69172373 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.68541132 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.67766995 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.66684077 |
| 84 | MP0001873_stomach_inflammation | 0.66563653 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.65569883 |
| 86 | MP0003045_fibrosis | 0.64624415 |
| 87 | MP0003795_abnormal_bone_structure | 0.64584396 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.64279183 |
| 89 | MP0008874_decreased_physiological_sensi | 0.63265813 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.63053949 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.60815517 |
| 92 | MP0000920_abnormal_myelination | 0.59866658 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.59417950 |
| 94 | MP0000490_abnormal_crypts_of | 0.59269215 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.58756016 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.58071322 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.57975160 |
| 98 | MP0004130_abnormal_muscle_cell | 0.57773482 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.57461162 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.57295264 |
| 101 | MP0010386_abnormal_urinary_bladder | 0.56254017 |
| 102 | MP0003329_amyloid_beta_deposits | 0.55923313 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.53176783 |
| 104 | MP0008873_increased_physiological_sensi | 0.51898581 |
| 105 | MP0002132_abnormal_respiratory_system | 0.51274833 |
| 106 | MP0005451_abnormal_body_composition | 0.51111262 |
| 107 | MP0008004_abnormal_stomach_pH | 0.50896668 |
| 108 | MP0003866_abnormal_defecation | 0.49769906 |
| 109 | MP0005171_absent_coat_pigmentation | 0.49563601 |
| 110 | MP0000609_abnormal_liver_physiology | 0.48909138 |
| 111 | * MP0005167_abnormal_blood-brain_barrier | 0.48568444 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48501221 |
| 113 | MP0003091_abnormal_cell_migration | 0.47851447 |
| 114 | MP0002133_abnormal_respiratory_system | 0.47470946 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.47197631 |
| 116 | MP0002090_abnormal_vision | 0.46845756 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.46677241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.13811124 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.34526088 |
| 3 | Eczematoid dermatitis (HP:0000976) | 7.08474864 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.33250406 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.30224615 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.25017907 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.19789468 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47210892 |
| 9 | Gingivitis (HP:0000230) | 4.41001081 |
| 10 | Stomatitis (HP:0010280) | 4.39163272 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.34512581 |
| 12 | Recurrent skin infections (HP:0001581) | 4.30027729 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.22459869 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.21767193 |
| 15 | Obstructive lung disease (HP:0006536) | 4.16435551 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.16435551 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 4.03826185 |
| 18 | Myositis (HP:0100614) | 4.02734530 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.98872146 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.98872146 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.98872146 |
| 22 | Orchitis (HP:0100796) | 3.93071803 |
| 23 | Optic neuritis (HP:0100653) | 3.88883383 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.88883383 |
| 25 | Glomerulonephritis (HP:0000099) | 3.86044566 |
| 26 | Encephalitis (HP:0002383) | 3.60152205 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57394988 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.56428252 |
| 29 | Basal ganglia calcification (HP:0002135) | 3.46135139 |
| 30 | Pustule (HP:0200039) | 3.44469723 |
| 31 | Increased IgM level (HP:0003496) | 3.44293347 |
| 32 | Thick nail (HP:0001805) | 3.35388386 |
| 33 | Increased IgE level (HP:0003212) | 3.33257325 |
| 34 | Vasculitis (HP:0002633) | 3.32055820 |
| 35 | Axonal loss (HP:0003447) | 3.26059412 |
| 36 | Periodontitis (HP:0000704) | 3.24811082 |
| 37 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.15711471 |
| 38 | Prostate neoplasm (HP:0100787) | 3.10210290 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 3.10063814 |
| 40 | Chest pain (HP:0100749) | 3.07699072 |
| 41 | Cellulitis (HP:0100658) | 3.06615696 |
| 42 | Recurrent viral infections (HP:0004429) | 3.06474190 |
| 43 | Disinhibition (HP:0000734) | 3.03472255 |
| 44 | Amyloidosis (HP:0011034) | 2.97408455 |
| 45 | Episodic fever (HP:0001954) | 2.94945967 |
| 46 | Petechiae (HP:0000967) | 2.89727742 |
| 47 | T lymphocytopenia (HP:0005403) | 2.88583234 |
| 48 | Meningitis (HP:0001287) | 2.85756929 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.84280385 |
| 50 | Nephritis (HP:0000123) | 2.80352767 |
| 51 | Urticaria (HP:0001025) | 2.73010202 |
| 52 | Recurrent pneumonia (HP:0006532) | 2.72797575 |
| 53 | Anorexia (HP:0002039) | 2.71400143 |
| 54 | Dysostosis multiplex (HP:0000943) | 2.65932389 |
| 55 | Agnosia (HP:0010524) | 2.64727200 |
| 56 | Pulmonary embolism (HP:0002204) | 2.64718258 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.64580425 |
| 58 | Hematochezia (HP:0002573) | 2.58645192 |
| 59 | Recurrent cutaneous fungal infections (HP:0011370) | 2.57926519 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.57926519 |
| 61 | Hypochromic anemia (HP:0001931) | 2.54906443 |
| 62 | Gangrene (HP:0100758) | 2.52590981 |
| 63 | Poor head control (HP:0002421) | 2.52096972 |
| 64 | Peritonitis (HP:0002586) | 2.51589387 |
| 65 | Loss of speech (HP:0002371) | 2.49343446 |
| 66 | Purpura (HP:0000979) | 2.49002263 |
| 67 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48146881 |
| 68 | Osteomyelitis (HP:0002754) | 2.46782130 |
| 69 | Leukocytosis (HP:0001974) | 2.44146282 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.43032844 |
| 71 | Tetraparesis (HP:0002273) | 2.41974999 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.40727561 |
| 73 | Abnormality of T cells (HP:0002843) | 2.40122771 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.39074252 |
| 75 | Premature loss of primary teeth (HP:0006323) | 2.38177121 |
| 76 | Abnormality of complement system (HP:0005339) | 2.37937571 |
| 77 | Recurrent lower respiratory tract infections (HP:0002783) | 2.37675796 |
| 78 | Gingival bleeding (HP:0000225) | 2.34216738 |
| 79 | Chronic otitis media (HP:0000389) | 2.33726408 |
| 80 | Arterial thrombosis (HP:0004420) | 2.30711134 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.26668901 |
| 82 | Increased serum ferritin (HP:0003281) | 2.24921569 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.23910350 |
| 84 | Granulocytopenia (HP:0001913) | 2.22423402 |
| 85 | Bone pain (HP:0002653) | 2.18339913 |
| 86 | Pathologic fracture (HP:0002756) | 2.15947873 |
| 87 | Colitis (HP:0002583) | 2.15771786 |
| 88 | Joint hemorrhage (HP:0005261) | 2.15693257 |
| 89 | Myocardial infarction (HP:0001658) | 2.15628135 |
| 90 | Vertigo (HP:0002321) | 2.15592054 |
| 91 | Abnormality of the endocardium (HP:0004306) | 2.14007801 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.12219847 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.12219847 |
| 94 | Mucopolysacchariduria (HP:0008155) | 2.10882333 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10882333 |
| 96 | Hemoptysis (HP:0002105) | 2.08027495 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 2.07757746 |
| 98 | Glomerulopathy (HP:0100820) | 2.07629533 |
| 99 | Lymphopenia (HP:0001888) | 2.07602423 |
| 100 | Vertebral compression fractures (HP:0002953) | 2.07204570 |
| 101 | Keratoconjunctivitis (HP:0001096) | 2.06542655 |
| 102 | Progressive visual loss (HP:0000529) | 2.05513179 |
| 103 | Epistaxis (HP:0000421) | 2.05318816 |
| 104 | Polyneuropathy (HP:0001271) | 2.04332803 |
| 105 | Abnormality of the peritoneum (HP:0002585) | 2.02752420 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 2.01648372 |
| 107 | Sepsis (HP:0100806) | 2.00429759 |
| 108 | Abnormality of the prostate (HP:0008775) | 1.99395049 |
| 109 | Microcytic anemia (HP:0001935) | 1.98539645 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98080598 |
| 111 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98080598 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98080598 |
| 113 | Acne (HP:0001061) | 1.97681222 |
| 114 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.97034585 |
| 115 | Keratitis (HP:0000491) | 1.96485352 |
| 116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95014200 |
| 117 | Complement deficiency (HP:0004431) | 1.93850737 |
| 118 | Gastrointestinal infarctions (HP:0005244) | 1.93389649 |
| 119 | Cheilitis (HP:0100825) | 1.93348409 |
| 120 | Albinism (HP:0001022) | 1.91182281 |
| 121 | Abnormality of the pleura (HP:0002103) | 1.90749533 |
| 122 | Prolonged bleeding time (HP:0003010) | 1.90117652 |
| 123 | Abnormality of the pericardium (HP:0001697) | 1.88073855 |
| 124 | Inflammation of the large intestine (HP:0002037) | 1.87709682 |
| 125 | Thyroiditis (HP:0100646) | 1.87427585 |
| 126 | Abnormality of T cell number (HP:0011839) | 1.86911783 |
| 127 | Upper motor neuron abnormality (HP:0002127) | 1.86027410 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 1.85879700 |
| 129 | Arthralgia (HP:0002829) | 1.85113009 |
| 130 | Restrictive lung disease (HP:0002091) | 1.84368775 |
| 131 | Gastrointestinal stroma tumor (HP:0100723) | 1.83053181 |
| 132 | Skin ulcer (HP:0200042) | 1.80686275 |
| 133 | Porencephaly (HP:0002132) | 1.79876658 |
| 134 | Eosinophilia (HP:0001880) | 1.79848091 |
| 135 | Spontaneous hematomas (HP:0007420) | 1.77888241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.06472151 |
| 2 | MAP3K14 | 5.02436935 |
| 3 | BLK | 4.43489608 |
| 4 | TBK1 | 3.66801622 |
| 5 | IRAK4 | 3.53221776 |
| 6 | IRAK3 | 3.07453228 |
| 7 | PBK | 2.99763007 |
| 8 | IKBKB | 2.83474474 |
| 9 | TYK2 | 2.80963792 |
| 10 | IKBKE | 2.77789906 |
| 11 | TXK | 2.46299959 |
| 12 | JAK3 | 2.28328193 |
| 13 | MAP4K1 | 2.24985688 |
| 14 | KIT | 2.21771701 |
| 15 | TNK2 | 2.04554841 |
| 16 | NEK9 | 2.03619865 |
| 17 | PIM2 | 1.97680175 |
| 18 | GRK6 | 1.91352975 |
| 19 | JAK1 | 1.83715187 |
| 20 | BMPR2 | 1.80112057 |
| 21 | TAOK1 | 1.71900127 |
| 22 | MAP3K3 | 1.66082649 |
| 23 | CHUK | 1.56170263 |
| 24 | CSK | 1.48190424 |
| 25 | SYK | 1.46014245 |
| 26 | TGFBR2 | 1.41410406 |
| 27 | PIM1 | 1.40095761 |
| 28 | MATK | 1.35852202 |
| 29 | ZAP70 | 1.34075628 |
| 30 | LYN | 1.32898563 |
| 31 | YES1 | 1.32690238 |
| 32 | BMX | 1.27000112 |
| 33 | BTK | 1.25594224 |
| 34 | HCK | 1.25292986 |
| 35 | MAP3K13 | 1.22499567 |
| 36 | CSF1R | 1.20559405 |
| 37 | TEC | 1.18427971 |
| 38 | MST4 | 1.11356397 |
| 39 | EIF2AK2 | 1.11194249 |
| 40 | NME2 | 1.10555313 |
| 41 | KSR2 | 1.09153667 |
| 42 | GRK7 | 1.08002272 |
| 43 | ABL2 | 1.06458025 |
| 44 | FGR | 1.03446460 |
| 45 | ERN1 | 1.03285049 |
| 46 | LCK | 1.03038641 |
| 47 | JAK2 | 1.01804924 |
| 48 | ERBB3 | 0.95070992 |
| 49 | SIK3 | 0.94685835 |
| 50 | MARK3 | 0.90231771 |
| 51 | TRPM7 | 0.86845799 |
| 52 | MST1R | 0.86136307 |
| 53 | PRKCD | 0.85049759 |
| 54 | MARK2 | 0.84586583 |
| 55 | TAOK2 | 0.83817184 |
| 56 | RPS6KA4 | 0.82637136 |
| 57 | CLK1 | 0.80633870 |
| 58 | PRKD2 | 0.80143679 |
| 59 | CDK19 | 0.79619825 |
| 60 | TESK2 | 0.79449584 |
| 61 | ADRBK2 | 0.77360776 |
| 62 | MAP3K12 | 0.76623891 |
| 63 | IRAK2 | 0.75874947 |
| 64 | PTK6 | 0.75147746 |
| 65 | CDC42BPA | 0.72288613 |
| 66 | DAPK2 | 0.70674529 |
| 67 | FES | 0.70042559 |
| 68 | TAOK3 | 0.69016171 |
| 69 | STK4 | 0.68785086 |
| 70 | IRAK1 | 0.66561210 |
| 71 | MAP3K5 | 0.65969426 |
| 72 | MAP3K2 | 0.65782907 |
| 73 | ABL1 | 0.65348464 |
| 74 | ARAF | 0.64165453 |
| 75 | PDK2 | 0.61392818 |
| 76 | STK10 | 0.61238257 |
| 77 | MAP3K11 | 0.57994774 |
| 78 | FGFR3 | 0.57949982 |
| 79 | LRRK2 | 0.57190512 |
| 80 | EGFR | 0.56976572 |
| 81 | MAP2K4 | 0.56468480 |
| 82 | EPHB1 | 0.56054401 |
| 83 | MAP2K3 | 0.53446794 |
| 84 | MAPK7 | 0.53081931 |
| 85 | CAMKK2 | 0.50747843 |
| 86 | PTK2B | 0.50215187 |
| 87 | MAP3K6 | 0.50129215 |
| 88 | STK11 | 0.49726615 |
| 89 | SGK3 | 0.44013619 |
| 90 | RPS6KA6 | 0.43680688 |
| 91 | MAP3K7 | 0.43606276 |
| 92 | DYRK1B | 0.43149063 |
| 93 | HIPK2 | 0.41571318 |
| 94 | ACVR1B | 0.41445978 |
| 95 | MAP2K6 | 0.40936342 |
| 96 | PDK1 | 0.39117922 |
| 97 | MOS | 0.38188468 |
| 98 | SMG1 | 0.37056837 |
| 99 | PRKCQ | 0.35949645 |
| 100 | ITK | 0.35936510 |
| 101 | KSR1 | 0.35853003 |
| 102 | MAPKAPK2 | 0.35367771 |
| 103 | NEK6 | 0.34872512 |
| 104 | PRKCZ | 0.32650088 |
| 105 | RAF1 | 0.32641640 |
| 106 | PDPK1 | 0.32128186 |
| 107 | ALK | 0.30732771 |
| 108 | CAMKK1 | 0.29868947 |
| 109 | RPS6KC1 | 0.29069969 |
| 110 | RPS6KL1 | 0.29069969 |
| 111 | RET | 0.28826742 |
| 112 | FGFR4 | 0.27672284 |
| 113 | CDK6 | 0.27513925 |
| 114 | IGF1R | 0.25138939 |
| 115 | SIK2 | 0.24524173 |
| 116 | RPS6KA2 | 0.24068837 |
| 117 | PRPF4B | 0.23527402 |
| 118 | STK24 | 0.22866437 |
| 119 | FYN | 0.22594117 |
| 120 | BMPR1B | 0.20948234 |
| 121 | ERBB4 | 0.20048159 |
| 122 | MAPK4 | 0.17706859 |
| 123 | MAP3K1 | 0.17388413 |
| 124 | RPS6KA5 | 0.17313897 |
| 125 | RPS6KA1 | 0.16245199 |
| 126 | EPHA3 | 0.16155096 |
| 127 | NLK | 0.15439309 |
| 128 | PRKG2 | 0.15271805 |
| 129 | MAPK12 | 0.14214179 |
| 130 | STK3 | 0.13992220 |
| 131 | INSR | 0.13367575 |
| 132 | PIK3CG | 0.12035712 |
| 133 | RIPK1 | 0.11508498 |
| 134 | MAPK3 | 0.11394968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.48604291 |
| 2 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.32586287 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.31996139 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.90133334 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.77135605 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.71788225 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.66933977 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58573551 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.51180900 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.41065608 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37166790 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.35717045 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.29338014 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.27638726 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.17091597 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14314119 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.12585843 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 2.06956330 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06641855 |
| 20 | Measles_Homo sapiens_hsa05162 | 2.03178885 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.92839538 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90347525 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.80787752 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.76940154 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75327933 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.71747786 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.64869705 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.58276579 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55592922 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53490047 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50367309 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50236427 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49618165 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43114409 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39368798 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.33311734 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32122101 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31912061 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.28019765 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26220215 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20648804 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.14474579 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09406020 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03679083 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02195384 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01007495 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.95846320 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92558887 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 0.92471585 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91781579 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91021301 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.87426795 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87208683 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.82750438 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82663258 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74157938 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72475391 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70195586 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67383016 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63546688 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62664200 |
| 62 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61878274 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.60806918 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59483310 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59017744 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56652792 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55563938 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55482521 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54147219 |
| 70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51957771 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50186749 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.47717368 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46756881 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46491869 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46315861 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45705064 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43690442 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42759733 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41223243 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40617053 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40226432 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40127237 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39282711 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37652693 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37459009 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36299298 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35970376 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35841596 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35057323 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.34884829 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33247391 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32571927 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32501907 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.32268884 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32015521 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29808229 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28468142 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27709157 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27399070 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23684316 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22265038 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19931174 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19542796 |
| 104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17021029 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14511887 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.13857034 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.13752301 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.13451623 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.11444685 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.11441938 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11347991 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10454741 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10052190 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.06589838 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.06541274 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.06457980 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.06113757 |

